New Hampshire Nurse Practitioner Association
Empowering Nurse Practitioners as Leaders in Healthcare

New Hampshire 8-Hour MAT Waiver Trainings

Posted over 2 years ago by Mary Bidgood-Wilson

This announcement has 1 attachment:

New Hampshire 8-Hour MAT Waiver Trainings

Helping states connect the dots to more e ectively address opioid use disorders

Three Training Dates:

Event Date: April 14, 2017
Location: Catholic Medical Center 100 McGregor St, Manchester, NH
Presenters: Colleen T. LaBelle, MSN, RN-BC, CARN and Laura Kehoe, MD
Registration Link: Click Here

Event Date: May 12, 2017
Location: Frisbie Memorial Hospital 11 Whitehall Rd, Rochester, NH
Presenters: Olivera Bogunovic, MD, and Laura Kehoe, MD
Registration Link: Click Here

Event Date: June 9, 2017
Location: Dartmouth-Hitchcock Medical Center 1 Medical Center Dr, Lebanon, NH
Presenters: Joji Suzuki, MD, and Sanchit Maruti, MD
Registration Link: Click Here

All trainings are free and held from 8:30 am to 5:00 pm. Please bring photo ID.

Residents may take the course and apply for their waiver when they receive their DEA license. They will need to maintain their certi cate of completion following the training.

Nurse practitioners (NPs) and physician assistants (PAs) who take this 8-hour MAT waiver course will receive a certi cate of completion and can apply it toward the 24-hour training requirement established by the Comprehensive Addiction and Recovery Act (CARA). For the additional 16 hours, PCSS-MAT is also providing NPs and PAs with the coursework FREE and together they meet the required training to be eligible to apply for the waiver to prescribe buprenorphine.

For more information on this initiative and SAMHSA-sponsored training opportunities, sign up for the Buprenorphine Waiver Management email list.

DATA 2000 Organization: American Academy of Addiction Psychiatry

Applying for the waiver to prescribe:

Upon completing the required courses (MD-8 hours, NP and PA-24 hours) participants will need to submit a Notice of Intent form (NOI) along with their certi cate(s) of completion, provided after completing the training, which veri es that they have completed the required coursework. A link to the NOI form application will be given following the training.

PCSS-MAT has a comprehensive library of materials with continuing education are available at no cost for healthcare providers to build con dence in preventing substance use disorders and treating SUDs and opioid use disorders (OUD).

PCSS-MAT also has a no-cost clinical coaching/mentoring program to provide one-on-one clinical expertise for primary care providers. You can post a question to a listserv with an addiction specialist and be matched with an addiction specialist.

Helpful Resources:

CME Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Addiction Psychiatry (AAAP) and the New Hampshire Medical Society, Anthem New Hampshire, and NH Department of Health and Human Services. AAAP is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Method of physician participation in the learning process: To be awarded a maximum of 8 AMA PRA Category 1 CreditsTM and a Buprenorphine Training Completion Certi cate you must complete all 8 hours of the course and receive a minimum cumulative score of 75% on the examination. Those passing the course will be able to complete the waiver application online. Approved by the NH Board of Medicine as Continuing Medical Education (CME) for the opioid prescribing competency requirement.

Questions? Email Seth Acton ( ADDITIONAL 16 HOURS AT AANP

Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (5U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily re ect the o cial policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


No comments yet.

Only active members can comment on this announcement.
To inquire about membership, please contact us.